Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Wailoo

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Health Technology Assessment (Winchester, England)|July 3, 2020
Mapping clinical outcomes to generic preference-based outcome measures: development and comparison of methodsMónica Hernández Alava, Allan Wailoo, Stephen Pudney, et al.
The Patient|February 1, 2024
Exploring the Factors that Drive Clinical Negligence Claims: Stated Preferences of Those Who Have Experienced Unintended HarmNyantara Wickramasekera, Arne Risa Hole, Donna Rowen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 1, 2021
A Review of the Psychometric Performance of Selected Child and Adolescent Preference-Based Measures Used to Produce Utilities for Child and Adolescent HealthDonna Rowen, Anju D Keetharuth, Edith Poku, et al.
Health Economics|February 26, 2004
Comprehensive decision analytical modelling in economic evaluation: a Bayesian approachNicola J Cooper, Alex J Sutton, Keith R Abrams, et al.
Health Policy OPEN|December 26, 2025
The NICE experience of designing and utilising severity weightsAllan Wailoo, Helen Bell Gorrod, Lorna Dunning, et al.
Rheumatology (Oxford, England)|April 29, 2014
Cost-effectiveness of treatment strategies using combination disease-modifying anti-rheumatic drugs and glucocorticoids in early rheumatoid arthritisAllan Wailoo, Mónica Hernández Alava, Ian C Scott, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 24, 2022
A Cost-Effectiveness Analysis of Remdesivir for the Treatment of Hospitalized Patients With COVID-19 in England and WalesRachid Rafia, Marrissa Martyn-St James, Sue Harnan, et al.
Pharmacoeconomics|June 29, 2013
Good practice guidelines for the use of statistical regression models in economic evaluationsBen Kearns, Roberta Ara, Allan Wailoo, et al.
BMJ Open|July 19, 2014
The safety of intravitreal bevacizumab monotherapy in adult ophthalmic conditions: systematic reviewEdith Poku, John Rathbone, Ruth Wong, et al.
BMJ (Clinical Research Ed.)|June 7, 2003
Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trialsNicola J Cooper, Alexander J Sutton, Keith R Abrams, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Health Technology Assessment (Winchester, England)|July 3, 2020
Mapping clinical outcomes to generic preference-based outcome measures: development and comparison of methodsMónica Hernández Alava, Allan Wailoo, Stephen Pudney, et al.
The Patient|February 1, 2024
Exploring the Factors that Drive Clinical Negligence Claims: Stated Preferences of Those Who Have Experienced Unintended HarmNyantara Wickramasekera, Arne Risa Hole, Donna Rowen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 1, 2021
A Review of the Psychometric Performance of Selected Child and Adolescent Preference-Based Measures Used to Produce Utilities for Child and Adolescent HealthDonna Rowen, Anju D Keetharuth, Edith Poku, et al.
Health Economics|February 26, 2004
Comprehensive decision analytical modelling in economic evaluation: a Bayesian approachNicola J Cooper, Alex J Sutton, Keith R Abrams, et al.
Health Policy OPEN|December 26, 2025
The NICE experience of designing and utilising severity weightsAllan Wailoo, Helen Bell Gorrod, Lorna Dunning, et al.
Rheumatology (Oxford, England)|April 29, 2014
Cost-effectiveness of treatment strategies using combination disease-modifying anti-rheumatic drugs and glucocorticoids in early rheumatoid arthritisAllan Wailoo, Mónica Hernández Alava, Ian C Scott, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 24, 2022
A Cost-Effectiveness Analysis of Remdesivir for the Treatment of Hospitalized Patients With COVID-19 in England and WalesRachid Rafia, Marrissa Martyn-St James, Sue Harnan, et al.
Pharmacoeconomics|June 29, 2013
Good practice guidelines for the use of statistical regression models in economic evaluationsBen Kearns, Roberta Ara, Allan Wailoo, et al.
BMJ Open|July 19, 2014
The safety of intravitreal bevacizumab monotherapy in adult ophthalmic conditions: systematic reviewEdith Poku, John Rathbone, Ruth Wong, et al.
BMJ (Clinical Research Ed.)|June 7, 2003
Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trialsNicola J Cooper, Alexander J Sutton, Keith R Abrams, et al.
Pageof 7